Loading
OT
Ocata Therapeutics, Inc. Stock: price and insider trades · United States
Ocata Therapeutics, Inc.: what insiders have been doing
Insider filings for Ocata Therapeutics, Inc. are scarce in the SEC (Form 4) feed, the latest one published on 11 February 2016. This page will fill in as new trades are disclosed. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
21
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Last declaration on 11 February 2016
Declarations21 total
277,500 sharesCommon StockSEC:0001104659-16-095952:0
56,000 sharesCommon StockSEC:0001104659-16-095958:0
31,000 sharesCommon StockSEC:0001104659-16-095957:0
25,000 sharesCommon StockSEC:0001104659-16-095967:0
51,000 sharesCommon StockSEC:0001104659-16-095954:0
12,500 sharesCommon StockSEC:0001104659-16-095971:0
21,834 sharesCommon StockSEC:0001104659-16-095956:0
231,509 sharesCommon StockSEC:0001104659-16-095976:0
56,000 sharesCommon StockSEC:0001104659-16-095973:0
252,206 sharesCommon StockSEC:0001104659-16-095964:0
15,530 sharesCommon StockSEC:0001104659-16-095964:1
15,530 sharesCommon StockSEC:0001104659-16-095964:2
21,417 sharesCommon StockSEC:0001104659-16-095972:0
2,500 sharesCommon StockSEC:0001179110-16-016920:0
1,250 sharesCommon StockSEC:0001179110-16-016921:0
1,250 sharesCommon StockSEC:0001179110-16-016919:0
1,250 sharesCommon StockSEC:0001179110-16-016918:0
1,250 sharesCommon StockSEC:0001179110-16-016916:0
0Common StockSEC:0001179110-16-016916:1
1,250 sharesCommon StockSEC:0001179110-16-016917:0
0Common StockSEC:0001179110-16-016916:2
21 of 21 declarations
About Ocata Therapeutics, Inc.
Ocata Therapeutics, Inc. is a biotechnology company focused on developing stem cell-based therapies for treating eye diseases. It is listed on NASDAQ under the ticker OCAT.
